dehydroepiandrosterone sulfate has been researched along with Debility in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aida, E; Asakawa, H; Eda, T; Fujihara, Y; Harada, M; Honda, M; Ito, T; Iwaya, C; Kayashima, Y; Kitajima, Y; Muta, K; Nawata, H; Tajima, M; Teruya, Y; Yamaguchi, N; Yanagita, I; Yanase, T; Yoshimoto, M; Yoshimoto, S | 1 |
1 other study(ies) available for dehydroepiandrosterone sulfate and Debility
| Article | Year |
|---|---|
Low serum albumin, aspartate aminotransferase, and body mass are risk factors for frailty in elderly people with diabetes-a cross-sectional study.
Topics: Aged; Aspartate Aminotransferases; Cross-Sectional Studies; Dehydroepiandrosterone Sulfate; Diabetes Mellitus, Type 2; Frailty; Humans; Risk Factors; Serum Albumin | 2020 |